Bladder Cancer Trial, Recruiting NCT06775977 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06775977
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with primary bladder cancer, confirmed through a lab test of tissue or cell samples
  • You have not had any surgery, chemotherapy, immunotherapy, or other treatments before the special ultrasound scan (CEUS) used in this trial

Who may not be able to join:

  • You have been confirmed to NOT have bladder cancer
  • You have previously had pelvic surgery, any bladder surgery, or have already received chemotherapy, radiotherapy, or immunotherapy
  • Your cancer has come back after previous treatment, or has spread to other parts of the body
  • You are allergic to ultrasound contrast agents (a dye used during the scan), or have certain heart or lung conditions that make this type of scan unsafe — such as a recent heart attack, chest pain (angina), heart failure, serious irregular heartbeat, a hole in the heart, severe high blood pressure in the lungs, uncontrolled high blood pressure, acute breathing difficulties, or chronic obstructive pulmonary disease (COPD) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luo, Prof., Department of Ultrasound in Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Phone: 020-34071020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Detection of Muscle Invasion in Bladder Cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov